Apellis Pharmaceuticals, Inc. (APLS) Insider Ownership

Historic Ownership Trends

According to recent filings covering the 90 days ending December 12, 2025, the three most significant insider holders at Apellis Pharmaceuticals are Chief Financial Officer Timothy Eugene Sullivan (171.33K shares), General Counsel David O. Watson (158.87K shares), Chief Research And Development Leslie Meltzer (61.80K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Venture Investments Ltd Morningside 12,806,342 18 Nov, 2021
Pascal Deschatelets Chief Scientific Officer 1,160,496 22 May, 2025
Cedric Francois Chief Executive Officer 639,551 18 Jul, 2025
Alec Machiels 388,978 03 Jan, 2025
A. Sinclair Dunlop 188,535 03 Jan, 2025
Timothy Eugene Sullivan Chief Financial Officer 171,332 23 Oct, 2025
David O. Watson General Counsel 158,866 18 Nov, 2025
Kelley Boucher Chief People Officer 97,658 03 Sep, 2025
Federico Grossi Chief Medical Officer 94,884 09 Jan, 2023
Caroline Baumal Chief Medical Officer 93,301 21 Jan, 2025
Adam J. Townsend Chief Commercial Officer 84,050 30 Jan, 2025
Mark Jeffrey Delong Chief Business & Strat Officer 83,945 12 Feb, 2025
Nur Nicholson Chief Technical Officer 83,664 30 Jan, 2025
Karen Lewis Chief People Officer 70,251 30 Jan, 2025
Lukas Scheibler Chief Research Officer 68,299 05 Dec, 2023
Leslie Meltzer Chief Research And Development 61,804 02 Sep, 2025
Jeffrey Eisele Chief Development Officer 55,312 30 Jan, 2025
James George Chopas VP/Chief Accounting Officer 53,468 16 Sep, 2025
Victoria L. Brown Program Team Lead 23,556 24 Jan, 2023
Paul R. Fonteyne 22,705 03 Jan, 2025
Stephanie Monaghan O'Brien 17,705 03 Jan, 2025
Gerald Chan 17,705 03 Jan, 2025
Craig A Wheeler 16,483 21 Apr, 2025
Keli Walbert 9,090 10 Jan, 2025
Nicole D Perry Vice President Accounting 4,847 03 Aug, 2021

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
17 Nov, 2025 David O. Watson Common Stock D 5,000 $20.06 108,730 D S
21 Oct, 2025 Timothy Eugene Sullivan Common Stock A 10,000 $10.03 120,936 D M
21 Oct, 2025 Timothy Eugene Sullivan Common Stock D 10,000 $28.03 110,936 D S
16 Oct, 2025 David O. Watson Common Stock D 5,000 $25.22 113,730 D S
30 Sep, 2025 A. Sinclair Dunlop Common Stock D 31,092 $22.58 33,979 I S
30 Sep, 2025 A. Sinclair Dunlop Common Stock D 3,837 $0.00 30,142 I J
19 Sep, 2025 A. Sinclair Dunlop - - 68,908 I
19 Sep, 2025 A. Sinclair Dunlop Common Stock D 31,092 $22.95 68,908 I S
19 Sep, 2025 A. Sinclair Dunlop Common Stock D 3,837 $0.00 65,071 I J
19 Sep, 2025 A. Sinclair Dunlop - - 65,071 I
16 Sep, 2025 David O. Watson Common Stock D 5,000 $24.34 118,730 D S
15 Sep, 2025 James George Chopas - - 53,468 D
15 Sep, 2025 James George Chopas Common Stock D 189 $24.19 53,468 D S
10 Sep, 2025 David O. Watson Common Stock D 20,000 $26.17 50,136 I S
08 Sep, 2025 Timothy Eugene Sullivan Common Stock A 15,000 $10.03 143,665 D M
08 Sep, 2025 Timothy Eugene Sullivan Common Stock D 32,729 $27.86 110,936 D S
08 Sep, 2025 Timothy Eugene Sullivan Common Stock D 10,000 $27.83 60,396 I S
02 Sep, 2025 Kelley Boucher - - 97,658 D
02 Sep, 2025 James George Chopas Common Stock D 548 $28.08 53,657 D S
02 Sep, 2025 Kelley Boucher Common Stock A 30,476 $0.00 97,658 D A